Wells Fargo & Company Corcept Therapeutics Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 44,070 shares of CORT stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,070

Previous 40,923 7.69%

Holding current value

$2.31 Million

Previous $1.33 Million 53.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$29.51 - $46.26 $92,867 - $145,580	3,147 Added 7.69%	44,070 $2.04 Million
Q2 2024 Aug 13, 2024	BUY	$22.21 - $34.48 $292,194 - $453,618	13,156 Added 47.38%	40,923 $1.33 Million
Q1 2024 May 10, 2024	SELL	$21.1 - $27.46 $674,419 - $877,703	-31,963 Reduced 53.51%	27,767 $699,000
Q4 2023 Feb 09, 2024	BUY	$24.82 - $32.88 $674,309 - $893,283	27,168 Added 83.43%	59,730 $1.94 Million
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $646,115 - $994,024	-29,409 Reduced 47.46%	32,562 $887,000
Q2 2023 Aug 15, 2023	BUY	$21.44 - $25.15 $636,253 - $746,351	29,676 Added 91.89%	61,971 $1.38 Million
Q1 2023 May 12, 2023	BUY	$19.2 - $24.47 $343,641 - $437,964	17,898 Added 124.32%	32,295 $699,000
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $46,244 - $69,447	2,318 Added 19.19%	14,397 $292,000
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $14,869 - $17,530	-602 Reduced 4.75%	12,079 $309,000
Q2 2022 Aug 12, 2022	SELL	$17.33 - $25.3 $1.69 Million - $2.46 Million	-97,400 Reduced 88.48%	12,681 $302,000
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $515,521 - $786,224	-31,187 Reduced 22.08%	110,081 $2.48 Million
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $589,779 - $804,996	-34,490 Reduced 19.62%	141,268 $2.8 Million
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $614,724 - $703,747	-31,236 Reduced 15.09%	175,758 $3.46 Million
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $721,915 - $883,144	-36,150 Reduced 14.87%	206,994 $4.56 Million
Q1 2021 May 13, 2021	BUY	$23.49 - $30.56 $95,533 - $124,287	4,067 Added 1.7%	243,144 $5.79 Million
Q4 2020 Feb 09, 2021	SELL	$16.78 - $27.3 $1.43 Million - $2.33 Million	-85,196 Reduced 26.27%	239,077 $6.26 Million
Q3 2020 Nov 05, 2020	SELL	$12.46 - $19.98 $1.05 Million - $1.68 Million	-84,047 Reduced 20.58%	324,273 $5.64 Million
Q2 2020 Aug 13, 2020	BUY	$11.0 - $18.26 $2.09 Million - $3.47 Million	190,177 Added 87.18%	408,320 $6.87 Million
Q1 2020 May 14, 2020	BUY	$10.11 - $14.04 $2.21 Million - $3.06 Million	218,143 New	218,143 $2.59 Million

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.62B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Corcept Therapeutics Inc Transaction History